Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes

NCT02265809 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators